Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
23%
OVERLAP
BY WEIGHT
BY WEIGHT
6
# OF OVERLAPPING HOLDINGS
HART
75
HOLDINGS
9%
ALSO IN PJP
PJP
29
HOLDINGS
21%
ALSO IN HART
SECTOR DRIFT (HART minus PJP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HART |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 5.4% | 5.3% | 5.3% |
|
PFIZER INC | 5.0% | 5.0% | 5.0% |
|
ABBOTT LABORATORIES | 5.7% | 5.0% | 5.0% |
|
JOHNSON & JOHNSON | 5.3% | 4.9% | 4.9% |
|
BRISTOL-MYERS SQUIBB CO | 5.1% | 2.7% | 2.7% |
HART Overweight Relative to PJP
 |
ASTRAZENECA PLC | 5.6% |
|
BOSTON SCIENTIFIC CORP | 5.4% |
 |
MEDTRONIC PLC | 5.4% |
 |
NOVARTIS AG | 5.3% |
|
ALPHABET INC. CLASS A | 5.0% |
|
APPLE INC | 4.9% |
 |
SANOFI-AVENTIS | 4.0% |
 |
NOVO NORDISK A/S-B | 4.0% |
|
ELEVANCE HEALTH INC | 2.8% |
|
NIKE INC -CL B | 2.7% |
HART Underweight Relative to PJP
|
MERCK & CO. INC. | -5.0% |
|
GILEAD SCIENCES INC | -5.0% |
|
AMGEN INC | -4.9% |
|
ABBVIE INC | -4.8% |
|
OCULAR THERAPEUTIX INC | -3.6% |
|
BIOSANTE PHARMACEUTICALS INC | -3.0% |
|
LIGAND PHARMACEUTICALS-CL B | -3.0% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | -3.0% |
|
VIATRIS, INC. | -2.8% |
|
INNOVIVA, INC. | -2.8% |